Interleukin-17 and innate immunity in infections and chronic inflammation.
about
A Review of Biologic Therapies Targeting IL-23 and IL-17 for Use in Moderate-to-Severe Plaque PsoriasisAnti-Inflammatory Activity of Natural ProductsCurrent Hypothesis for the Relationship between Dietary Rice Bran Intake, the Intestinal Microbiota and Colorectal Cancer PreventionAutoimmunity in 2015.Differential Th17 response induced by the two clades of the pandemic ST258 Klebsiella pneumoniae clonal lineages producing KPC-type carbapenemase.IL-17A Monoclonal Antibody Partly Reverses the Glucocorticoids Insensitivity in Mice Exposed to Ozonec.IL-17A impairs host tolerance during airway chronic infection by Pseudomonas aeruginosaSingle Nucleotide Polymorphisms in IL17A and IL6 Are Associated with Decreased Risk for Pulmonary Tuberculosis in Southern Brazilian Population.Natural Th17 cells are critically regulated by functional medullary thymic microenvironments.Distinct interferon-gamma and interleukin-9 expression in cutaneous and oral lichen planus.Association between interleukin-17 gene polymorphisms and risk of coronary artery disease.Site-specific gene expression profiling as a novel strategy for unravelling keloid disease pathobiology.Adipose tissue fibrosis in human cancer cachexia: the role of TGFβ pathway.Regulation of tissue infiltration by neutrophils: role of integrin α3β1 and other factors.The Chinese Herbal Medicine Formula mKG Suppresses Pulmonary Fibrosis of Mice Induced by Bleomycin.Correlation of Surface Toll-Like Receptor 9 Expression with IL-17 Production in Neutrophils during Septic Peritonitis in Mice Induced by E. coli.Altered expression of intracellular Toll-like receptors in peripheral blood mononuclear cells from patients with alopecia areataDevelopment of rheumatoid arthritis during treatment of multiple sclerosis with interferon beta 1-a. Coincidence of two conditions or a complication of treatment: A case reportNovel adjuvant Alum-TLR7 significantly potentiates immune response to glycoconjugate vaccines.Meta-Analysis for the Association between Polymorphisms in Interleukin-17A and Risk of Coronary Artery DiseaseMaking sense of the cause of Crohn's - a new look at an old disease.Corticotropin-releasing hormone improves survival in pneumococcal pneumonia by reducing pulmonary inflammation.IL-17 contributed to the neuropathic pain following peripheral nerve injury by promoting astrocyte proliferation and secretion of proinflammatory cytokines.Neutrophil migration in infection and wound repair: going forward in reverse.Detection of Th17/Treg cells and related factors in gingival tissues and peripheral blood of rats with experimental periodontitisThe role of lymphocytes in the development and treatment of alopecia areata.Secukinumab (AIN-457) for the treatment of Psoriasis.Emerging drugs for psoriatic arthritis.PAPA, PASH and PAPASH Syndromes: Pathophysiology, Presentation and Treatment.Anti-interleukin-17 treatment of psoriasis.The Inflammatory Response in Psoriasis: a Comprehensive Review.Pyoderma gangrenosum and its syndromic forms: evidence for a link with autoinflammation.Psoriatic arthritis and psoriasis: differential diagnosis.A review of emerging IL-17 inhibitors in the treatment of psoriasis focusing on preclinical through phase II studies.Brodalumab for the treatment of psoriasis.IL-17: overview and role in oral immunity and microbiome.Dermatologic Manifestations of Monogenic Autoinflammatory Diseases.Association between plasma interleukin-17 levels and risk of psoriasis: a meta-analysis.IL-17 and IL-22 in immunity: Driving protection and pathology.Mold and Human Health: a Reality Check.
P2860
Q26771682-8ED9A38A-0F8E-4744-896B-07FFE064294EQ28073444-77E3988E-3E5E-4DEB-8BCA-B723C93A7994Q28080177-535F66B6-7250-450F-8DAA-066CF9E1E955Q30248983-1969D48B-EB43-4A5D-B7D9-BB6058CC1DB2Q30402773-D4080317-51DE-46A5-92FA-D9F1F445BE7DQ33676504-A8F9BEAE-8D95-41BA-846D-1A37EBD4A920Q34527023-58729843-1CE6-4650-B89B-44426CB89429Q35913514-B3F96EDA-FF20-48F1-B468-29561FAEDE40Q36062664-4EBC3D50-F206-4DD2-88EA-03AB46A20E2DQ36151744-F2B2D6FB-B431-4F0C-9480-A5AC3E3092DBQ36261996-1DE7417A-F68F-4C67-83EC-FF70B784D8C9Q36296731-E957B902-5A6D-4624-AF6A-895724C73B0BQ36306603-82F82288-52C3-46AE-8FAF-0E409F285F93Q36342909-54E39696-4C89-4B04-90FD-E00B8838B626Q36667164-0FDB4C62-E176-4653-9790-71AD22A31557Q36670361-A042D969-DEF1-45F6-93B9-67617FB1E5F9Q36783663-1CE6839C-F057-488D-8799-1C953EB22F6FQ37106606-7EDFC106-410E-4E99-AAD2-CDCFFE23AD41Q37112739-44C40678-AF82-483F-86FF-BB5C1CE8880AQ37128843-765DEDAF-EEC1-40EF-839E-C1840ACB2417Q37577712-5710A02D-9C3D-417D-A72D-B0957ECD1E85Q37599587-A830FC39-FC54-4BE1-8763-E4EC3C6C98D7Q37707592-86874137-ED4B-47BA-9EAC-3FA1263C47B8Q37722754-5161824E-3424-4B20-A11A-3A6B17EF55E2Q37736288-5AD4B759-3DEE-46DD-87DC-A70080A5B29BQ38627998-BC917692-D5C0-4592-A2FF-44906FEF97A8Q38662868-7DA5886B-6849-49EA-B048-93FCF629BCFDQ38710642-5C1D2CEB-C09F-4B90-91F4-8E46F08DEE16Q38753451-3E8CE5C5-C833-4D5C-83EC-1BD3851D7DE0Q38760881-4C75602B-9EAA-430F-8C7D-A57DAA639CF2Q38792930-0AA06254-303D-463E-BE60-DAB88AAAB4A6Q38815373-3893BB2C-E3E8-4704-967D-676C43F79E6EQ38828427-F3203984-BB0B-4753-AA26-F4C7A5E1E7B4Q38968548-84330C6A-0FEB-40CB-B235-5C6B54606EEDQ38975719-9D1DF7F9-6289-4485-BF90-CFD4BD6BD5C1Q38986139-2F250F05-78C4-45C5-85B6-664D575A5059Q39021328-A860D55B-35B6-4F14-92D1-8CF9309552D0Q39031468-87FA0EC3-C094-4A62-A436-DF7BC7B5FEF7Q39179415-16DE1358-6A19-4448-87B1-1C7F71BB173AQ39181451-364C0E81-7A5B-4AB5-80BF-980AD6CB0AE6
P2860
Interleukin-17 and innate immunity in infections and chronic inflammation.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Interleukin-17 and innate immunity in infections and chronic inflammation.
@en
type
label
Interleukin-17 and innate immunity in infections and chronic inflammation.
@en
prefLabel
Interleukin-17 and innate immunity in infections and chronic inflammation.
@en
P50
P1476
Interleukin-17 and innate immunity in infections and chronic inflammation.
@en
P2093
Natasa Isailovic
P356
10.1016/J.JAUT.2015.04.006
P577
2015-05-18T00:00:00Z